Cogent Total Assets from 2010 to 2024

COGT Stock

USD 9.58 0.05 0.52%

Cogent Biosciences Total Assets yearly trend continues to be comparatively stable with very little volatility. Total Assets will likely drop to about 186.6 M in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2017-12-31

Previous Quarter

429.9 M

Current Value

384 M

Quarterly Volatility

137.9 M

Covid

Check Cogent Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cogent Biosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.7 M, Interest Expense of 4.8 M or Selling General Administrative of 36.1 M, as well as many indicators such as Price To Sales Ratio of 12.32, Dividend Yield of 0.0 or PTB Ratio of 1.23. Cogent financial statements analysis is a perfect complement when working with Cogent Biosciences Valuation or Volatility modules.

Check out the analysis of Cogent Biosciences Correlation against competitors.

For more information on how to buy Cogent Stock please use our How to Invest in Cogent Biosciences guide.

Latest Cogent Biosciences' Total Assets Growth Pattern

Below is the plot of the Total Assets of Cogent Biosciences over the last few years. Total assets refers to the total amount of Cogent Biosciences assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Cogent Biosciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Cogent Biosciences' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cogent Biosciences' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 313.44 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Cogent Total Assets Regression Statistics

	Arithmetic Mean	133,146,308
	Geometric Mean	107,605,453
	Coefficient Of Variation	71.44
	Mean Deviation	82,419,744
	Median	75,550,000
	Standard Deviation	95,115,564
	Sample Variance	9047T
	Range	264.3M
	R-Value	0.75
	Mean Square Error	4323.3T
	R-Squared	0.56
	Significance	0
	Slope	15,862,619
	Total Sum of Squares	126657.6T

Cogent Total Assets History

	2024	186.6 M
	2023	313.4 M
	2022	300.8 M
	2021	232.1 M
	2020	250.9 M
	2019	49.4 M
	2018	85.9 M

Other Fundumenentals of Cogent Biosciences

Intangibles To Total Assets

Cogent Biosciences Total Assets component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Short Term Investments	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Net Invested Capital	Net Working Capital	Capital Stock	Net Tangible Assets	Property Plant Equipment	Capital Surpluse
Total Assets		1.0	0.34	-0.59	-0.84	0.64	0.59	0.65	1.0	0.64	0.81	0.93	0.98	0.9	0.98	-0.41	0.83
Total Stockholder Equity	1.0		0.31	-0.66	-0.81	0.6	0.53	0.57	1.0	0.68	0.79	0.93	0.99	0.93	0.96	-0.47	0.78
Current Deferred Revenue	0.34	0.31		0.23	-0.67	0.76	0.78	0.53	0.32	0.36	0.67	0.42	0.33	0.22	0.43	-0.23	0.53
Net Debt	-0.59	-0.66	0.23		0.2	0.1	0.22	0.2	-0.65	-0.71	-0.19	-0.53	-0.68	-0.82	-0.44	0.69	-0.06
Retained Earnings	-0.84	-0.81	-0.67	0.2		-0.94	-0.87	-0.73	-0.81	-0.56	-0.99	-0.88	-0.83	-0.7	-0.92	0.37	-0.9
Accounts Payable	0.64	0.6	0.76	0.1	-0.94		0.95	0.75	0.6	0.32	0.94	0.69	0.61	0.46	0.77	-0.23	0.86
Short Term Investments	0.59	0.53	0.78	0.22	-0.87	0.95		0.82	0.54	0.18	0.86	0.58	0.53	0.35	0.71	-0.04	0.85
Total Liab	0.65	0.57	0.53	0.2	-0.73	0.75	0.82		0.58	0.09	0.71	0.6	0.53	0.26	0.74	0.26	0.93
Total Current Assets	1.0	1.0	0.32	-0.65	-0.81	0.6	0.54	0.58		0.67	0.79	0.92	0.99	0.92	0.96	-0.47	0.78
Short Term Debt	0.64	0.68	0.36	-0.71	-0.56	0.32	0.18	0.09	0.67		0.57	0.75	0.74	0.78	0.59	-0.7	0.33
Common Stock	0.81	0.79	0.67	-0.19	-0.99	0.94	0.86	0.71	0.79	0.57		0.89	0.81	0.67	0.89	-0.35	0.88
Net Invested Capital	0.93	0.93	0.42	-0.53	-0.88	0.69	0.58	0.6	0.92	0.75	0.89		0.94	0.84	0.93	-0.42	0.8
Net Working Capital	0.98	0.99	0.33	-0.68	-0.83	0.61	0.53	0.53	0.99	0.74	0.81	0.94		0.95	0.95	-0.52	0.75
Capital Stock	0.9	0.93	0.22	-0.82	-0.7	0.46	0.35	0.26	0.92	0.78	0.67	0.84	0.95		0.83	-0.68	0.53
Net Tangible Assets	0.98	0.96	0.43	-0.44	-0.92	0.77	0.71	0.74	0.96	0.59	0.89	0.93	0.95	0.83		-0.35	0.91
Property Plant Equipment	-0.41	-0.47	-0.23	0.69	0.37	-0.23	-0.04	0.26	-0.47	-0.7	-0.35	-0.42	-0.52	-0.68	-0.35		-0.06
Capital Surpluse	0.83	0.78	0.53	-0.06	-0.9	0.86	0.85	0.93	0.78	0.33	0.88	0.8	0.75	0.53	0.91	-0.06

Click cells to compare fundamentals

About Cogent Biosciences Financial Statements

Cogent Biosciences shareholders use historical fundamental indicators, such as Total Assets, to determine how well the company is positioned to perform in the future. Although Cogent Biosciences investors may analyze each financial statement separately, they are all interrelated. The changes in Cogent Biosciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on Cogent Biosciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

		Last Reported	Projected for Next Year
	Total Assets	313.4 M	186.6 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Cogent Stock Analysis

When running Cogent Biosciences' price analysis, check to measure Cogent Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cogent Biosciences is operating at the current time. Most of Cogent Biosciences' value examination focuses on studying past and present price action to predict the probability of Cogent Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cogent Biosciences' price. Additionally, you may evaluate how the addition of Cogent Biosciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC